You are currently viewing a new version of our website. To view the old version click .

New Approaches to Counteract Drug Resistance in Cancer

This special issue belongs to the section “Medicinal Chemistry“.

Special Issue Information

Dear Colleagues,

Drug resistance in cancer, either intrinsic or acquired, is a major impediment to the success of cancer treatment. This clinical problem has proven very difficult to resolve, due to several factors, such as intratumor heterogeneity and tumor dynamics, together with the presence of cancer stem cells in tumors and the intercellular transfer of drug resistance mediated by extracellular vesicles (such as exosomes or microvesicles). This Special Issue of Molecules intends to collect state-of-the-art original research and review articles on new approaches to counteract drug resistance in cancer, which may include but are not exclusively limited to articles on: novel compounds or small molecules designed for drug targets responsible for drug resistance, compounds isolated from natural products with chemosensitizing effects, new RNAi therapeutics, based on antimiRs or siRNAs, designed towards targets responsible for drug resistance, or innovative drug delivery approaches to improve response to therapy. Articles on the development of new methods to detect resistance to antitumor drugs will also be considered.

Dr. Helena Vasconcelos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cancer
  • drug resistance
  • multidrug resistance
  • chemoresistance
  • chemosensitisation
  • drug-efflux pumps
  • ATP-binding cassette (ABC) transporters
  • Apoptosis
  • Autophagy
  • p53
  • mutations
  • DNA repair
  • tumor-microenvironment interactions
  • cancer stem cells
  • natural products
  • small molecules
  • synthesized compounds
  • RNAi
  • siRNAs
  • microRNAs
  • antimiRs
  • drug delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Molecules - ISSN 1420-3049